NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
May 09 04:00PM ET
22.28
Dollar change
-0.69
Percentage change
-3.00
%
IndexS&P 500 P/E16.15 EPS (ttm)1.38 Insider Own0.06% Shs Outstand5.68B Perf Week-7.93%
Market Cap126.67B Forward P/E7.23 EPS next Y3.08 Insider Trans0.50% Shs Float5.68B Perf Month-0.93%
Income7.87B PEG- EPS next Q0.56 Inst Own68.11% Short Float1.89% Perf Quarter-13.44%
Sales62.46B P/S2.03 EPS this Y-3.18% Inst Trans-0.64% Short Ratio2.04 Perf Half Y-20.40%
Book/sh15.89 P/B1.40 EPS next Y2.40% ROA3.67% Short Interest107.43M Perf Year-19.77%
Cash/sh3.05 P/C7.31 EPS next 5Y-0.28% ROE8.62% 52W Range20.92 - 31.54 Perf YTD-16.02%
Dividend Est.1.71 (7.65%) P/FCF11.29 EPS past 5Y-13.25% ROI5.32% 52W High-29.36% Beta0.55
Dividend TTM2.12 (9.52%) Quick Ratio0.96 Sales past 5Y17.19% Gross Margin66.93% 52W Low6.53% ATR (14)0.69
Dividend Ex-DateMay 09, 2025 Current Ratio1.26 EPS Y/Y TTM2770.58% Oper. Margin27.53% RSI (14)39.55 Volatility2.39% 2.79%
Employees81000 Debt/Eq0.69 Sales Y/Y TTM13.38% Profit Margin12.59% Recom2.40 Target Price28.26
Option/ShortYes / Yes LT Debt/Eq0.64 EPS Q/Q-5.13% Payout119.94% Rel Volume0.74 Prev Close22.97
Sales Surprise-1.47% EPS Surprise38.22% Sales Q/Q-7.82% EarningsApr 29 BMO Avg Volume52.59M Price22.28
SMA20-2.60% SMA50-8.16% SMA200-16.78% Trades Volume38,935,886 Change-3.00%
Date Action Analyst Rating Change Price Target Change
Apr-22-25Initiated Cantor Fitzgerald Neutral $24
Dec-10-24Resumed BofA Securities Neutral $29
Nov-15-24Initiated Wolfe Research Underperform $25
Oct-25-24Resumed Citigroup Neutral $30
Oct-17-24Initiated Bernstein Mkt Perform $32
Aug-07-24Upgrade Daiwa Securities Neutral → Outperform
Mar-22-24Downgrade Argus Buy → Hold
Feb-23-24Initiated Guggenheim Buy $36
Jan-04-24Downgrade TD Cowen Outperform → Market Perform $32
Oct-20-23Resumed UBS Neutral $36 → $34
Today 12:44PM
09:55AM
08:23AM
08:12AM
May-08-25 10:01PM
11:50AM Loading…
11:50AM
09:55AM
05:45AM
04:00AM
12:30AM
May-07-25 04:51PM
02:54PM
01:50PM
11:35AM
10:32AM
05:30AM Loading…
05:30AM
May-06-25 06:15PM
01:25PM
09:54AM
04:33AM
May-05-25 02:49PM
09:00AM
08:22AM
08:10AM
08:00AM
07:30AM
May-04-25 11:20AM
May-03-25 08:30AM
04:51AM
01:26AM
01:19PM Loading…
May-02-25 01:19PM
10:00AM
09:01AM
08:59AM
07:30AM
03:51AM
03:03AM
May-01-25 09:05PM
01:30PM
12:34PM
12:06PM
11:51AM
11:22AM
08:57AM
08:54AM
08:45AM
08:40AM
07:15AM
04:50AM
04:15AM
03:17AM
Apr-30-25 04:27PM
09:10AM
09:08AM
07:05AM
07:04AM
06:15AM
04:51AM
04:51AM
04:33AM
04:24AM
03:15AM
03:11AM
02:55AM
Apr-29-25 08:32PM
05:12PM
04:19PM
04:14PM
04:01PM
03:47PM
03:47PM
03:46PM
03:20PM
02:45PM
02:33PM
02:11PM
02:00PM
01:46PM
01:16PM
12:36PM
11:34AM
11:22AM
11:11AM
10:52AM
10:32AM
10:31AM
10:29AM
10:00AM
09:28AM
09:14AM
08:59AM
08:49AM
08:30AM
08:29AM
08:24AM
07:55AM
07:46AM
07:45AM
07:12AM
07:06AM
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dolsten MikaelFormer OfficerMay 05 '25Proposed Sale23.8755,0001,312,736May 05 04:45 PM
DAMICO JENNIFER B.SVP & ControllerMar 04 '25Sale25.932,50064,82511,850Mar 06 01:57 PM
DAMICO JENNIFER B.SVP & ControllerFeb 27 '25Option Exercise31.3122,416701,84531,063Mar 03 05:39 PM
SUSMAN SALLYExecutive Vice PresidentFeb 27 '25Option Exercise31.3185,1822,667,048250,866Mar 03 05:38 PM
SAHNI PAYALExecutive Vice PresidentFeb 27 '25Option Exercise31.3119,054596,58144,242Mar 03 05:38 PM
McDermott MichaelExecutive Vice PresidentFeb 27 '25Option Exercise31.3148,4191,515,999122,413Mar 03 05:37 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 27 '25Option Exercise31.31156,9144,912,977309,790Mar 03 05:37 PM
Fonseca LidiaExecutive Vice PresidentFeb 27 '25Option Exercise31.3172,6292,274,014111,534Mar 03 05:36 PM
BOURLA ALBERTChairman & CEOFeb 27 '25Option Exercise31.31582,82318,248,188931,744Mar 03 05:36 PM
McDermott MichaelExecutive Vice PresidentFeb 22 '25Option Exercise30.1711,125335,64187,636Feb 25 07:38 PM
DAMICO JENNIFER B.SVP & ControllerFeb 22 '25Option Exercise30.178,741263,71617,602Feb 25 07:38 PM
BOURLA ALBERTChairman & CEOFeb 22 '25Option Exercise30.17238,3997,192,498570,436Feb 25 07:06 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 22 '25Option Exercise30.1785,8242,589,310232,775Feb 25 07:05 PM
SAHNI PAYALExecutive Vice PresidentFeb 22 '25Option Exercise30.1712,714383,58137,099Feb 25 07:04 PM
SUSMAN SALLYExecutive Vice PresidentFeb 22 '25Option Exercise30.1763,5731,917,997225,184Feb 25 07:02 PM
BOSHOFF CHRISTOFFELPresident, R&DFeb 22 '25Option Exercise30.178,741263,716159,085Feb 25 06:58 PM
BLAYLOCK RONALD EDirectorFeb 13 '25Buy25.6519,457499,07227,707Feb 14 05:16 PM
Gottlieb ScottDirectorOct 30 '24Buy28.241,00028,24010,000Oct 31 04:06 PM
DAMICO JENNIFER B.SVP & ControllerAug 13 '24Sale28.665,154147,7148,582Aug 14 03:47 PM